NDC 49281-246 - IMOVAX RABIES
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49281-246
- Package NDCs from labels
- 49281-246-58
- Manufacturer
- Sanofi Vaccines US Inc. | Sanofi Winthrop Industrie
- Effective date
- 2026-02-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| IMOVAX RABIES - Sanofi Vaccines US Inc. | Sanofi Winthrop Industrie | Sanofi Vaccines US Inc. | Sanofi Winthrop Industrie | 2026-02-02 | VACCINE LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49281-246-58 | IMOVAX RABIES | 1 mL in 1 VIAL, SINGLE-USE | INJECTION, POWDER, LYOPHILIZED, | 1 mL | 2.5 [iU] in 1mL | 24 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) | ACTIVE INGREDIENT | C4HQF74XMW | IMOVAX RABIES (RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) AND WATER) KIT [SANOFI PASTEUR INC.] | 6 | |
| RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) | ACTIVE MOIETY | C4HQF74XMW | IMOVAX RABIES (RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) AND WATER) KIT [SANOFI PASTEUR INC.] | 6 | |
| ALBUMIN (HUMAN) | INACTIVE INGREDIENT | ZIF514RVZR | IMOVAX RABIES (RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) AND WATER) KIT [SANOFI PASTEUR INC.] | 6 | |
| NEOMYCIN SULFATE | INACTIVE INGREDIENT | 057Y626693 | IMOVAX RABIES (RABIES VIRUS STRAIN PM-1503-3M ANTIGEN (PROPIOLACTONE INACTIVATED) AND WATER) KIT [SANOFI PASTEUR INC.] | 6 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triple Antibiotic | POLYMYXIN B SULFATE, BACITRACIN ZINC AND NEOMYCIN SULFATE | Proficient Rx LP | 524d65e7-9dc6-47b0-a924-46a765fa1869 | 2023-12-01 | Warnings | 057Y626693 |
| Genuine First Aid Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | GFA Production(Xiamen) Co.,Ltd | 0aaee474-cf35-8b39-e063-6294a90a815c | 2023-11-21 | Warnings | 057Y626693 |
| Sheffield Triple Antibiotic Plus Pain Relief | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE, PRAMOXINE HYDROCHLORIDE | Sheffield Pharmaceuticals LLC | 485a779c-017b-4064-a446-e5073c1bdb07 | 2023-11-20 | Warnings | 057Y626693 |
| EVERLIT CARE Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | EVERLIT GLOBAL INC. | e9157891-fc05-41a1-8a86-761a9ae56f8a | 2023-11-14 | Warnings | 057Y626693 |
| Neomycin and Polymyxin B Sulfates and Dexamethasone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND DEXAMETHASONE | A-S Medication Solutions | 0d273133-0ce9-4fe6-b873-7f85aac25486 | 2023-11-01 | Warnings, Adverse reactions | 057Y626693 |
| Family wellness | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | FRONT PHARMACEUTICAL PLC | bd3b8146-6271-488d-bf79-0bb659123b31 | 2023-10-27 | Warnings | 057Y626693 |
| Family Wellness Antiseptic and Pain Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, PRAMOXINE HYDROCHLORIDE | FRONT PHARMACEUTICAL PLC | cb7fdcde-2bd8-4834-ba4e-4d6fd1512599 | 2023-10-26 | Warnings | 057Y626693 |
| GENUINE FIRST AID Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Nantong Health & Beyond Hygienic Products Inc. | 23abfe12-5b50-4b49-878e-4fcdb6c341fd | 2023-10-19 | Warnings | 057Y626693 |
| EVERLIT CARE Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Nantong Health & Beyond Hygienic Products Inc. | f4921508-c32f-426f-a2f0-16c3acbd4713 | 2023-10-14 | Warnings | 057Y626693 |
| ANUBISMED | HA HYALURONIC | ANUBIS COSMETICS SL | eac771e2-4c1b-3808-e053-2995a90ac5fc | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | SPF 50 BROAD SPECTRUM PROTECTION FLUID EMULSION | ANUBIS COSMETICS SL | e99d92c4-8768-9c0a-e053-2a95a90a609e | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | AZELAIC ACID, SALICYLIC ACID | ANUBIS COSMETICS SL | ebf3153d-30f5-54e4-e053-2995a90a74b1 | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | GLYCOLIC ACID, CITRIC ACID, LACTIC ACID, KOJIC ACID | ANUBIS COSMETICS SL | eca95dde-cb57-2ab6-e053-2995a90af84f | 2023-09-05 | Warnings | 059QF0KO0R |
| AnubisMed | SODIUM BICARBONATE, ALOE BARBADENSIS LEAF JUICE, IMIDAZOLIDINYL UREA | ANUBIS COSMETICS SL | ebf4b3ab-34e1-185a-e053-2a95a90ace3a | 2023-09-05 | Warnings | 059QF0KO0R |
| Anubis Barcelona | GLYCERIN, SORBITOL, ALOE BARBADENSIS LEAF JUICE | ANUBIS COSMETICS SL | eb651769-4d98-2b3b-e053-2a95a90a36b0 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | DMAE | ANUBIS COSMETICS SL | f22b212d-d21d-5984-e053-2995a90a683e | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | DMAE, ZIRHAFIRM | ANUBIS COSMETICS SL | f2274f8c-08aa-eb02-e053-2a95a90a3998 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | PEG-40 HYDROGENATED CASTOR OIL, PROPYLENE GLYCOL, ALLANTOIN | ANUBIS COSMETICS SL | eb9244ea-6102-3cbe-e053-2a95a90ab8f6 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona Vital Line | HYDROLYZED ELASTIN, HYDROLYSED COLLAGEN, COCOGLYCERIDES | ANUBIS COSMETICS SL | ebe024f7-7c45-ad60-e053-2995a90a45d6 | 2023-09-01 | Warnings | 059QF0KO0R |
| Anubis Barcelona | PROTEOGLYCAN, GLYCERIN, BUTYLENE GLYCOL | ANUBIS COSMETICS SL | ebdddcec-f5da-51fe-e053-2995a90a6167 | 2023-09-01 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.